Sitemap - 2026 - Big Pharma Sharma

Last Week Tonight in BioPharma, Week of June 15, 2026

Cell Therapy is Making Progress Against Solid Tumors — But is Anyone Noticing?

Last Week Tonight in BioPharma: Week of June 8th, 2026

ASCO 2026: Attention might be on the Wrong Drug in Frontline Lung Cancer

Last Week Tonight in BioPharma: Week of June 1st, 2026

Last Week Tonight in BioPharma: Week of May 25th, 2026

ChatGPT, Claude, or Gemini? Big Pharma Is Choosing Sides

Last Week Tonight in BioPharma: Week of May 18, 2026

Last Week Tonight in BioPharma: Week of May 11th, 2026

We Know JAK About Myelofibrosis

Last Week Tonight in BioPharma: Week of May 4th

Last Week Tonight in Biopharma: Week of April 27th, 2026

Should You Be Allowed to Bet on Whether a Cancer Drug Works?

Last Week Tonight in BioPharma | Week of April 21st, 2026

Last Week Tonight in BioPharma: April 11th - April 19th

The GLP-1 You Probably Haven't Heard Of

Last Week Tonight in BioPharma: April 4th - April 10th

Last Week Tonight in BioPharma: March 28th - April 3rd

Biogen’s Great Molt is Complete

Last Week Tonight in BioPharma: March 20th - 27th

Reclaiming the Narrative: What BioPharma Must Learn From Tech Before It's Too Late

Who's Actually Earning Their Seat at the Table?

Drug Dealin Ep. 9: Using AI to Find Novel Treatment Options

Why Gilead Really Bought Arcellx

The FDA Decision That Just Setback America's mRNA Vaccine Industry

Consulting & Advisory Work

Drug Dealin Ep. 8: 2026 Predictions

Big Pharma at JPM 2026: M&A, Obesity, and China

Six Biotechs Getting Acquired in 2026